Page 107 - Heca News Today

As the devastating Delta variant surge eases in many regions of the world, scientists are charting when, and where, COVID-19 will transition to an endemic disease in 2022 and beyond, according to Reuters interviews with over a dozen leading disease experts.

Bharat Biotech's COVID-19 vaccine has been granted an extension of shelf life for up to 12 months from the date of manufacture by India's drug regulator, the company said on Wednesday.

Several hundred people blocked traffic in the centre of the Ukrainian capital Kyiv on Wednesday in a protest against coronavirus restrictions and mandatory vaccinations, which the government introduced to curb new infections.

Securities analysts revised their ratings and price targets on several Canadian companies, including Air Canada, Equitable Group and Thomson Reuters on Wednesday.

Securities analysts revised their ratings and price targets on several European companies, including ABB, Antin Infrastructure Partners Sas and Schindler Holding, on Wednesday.

Romania's ruling centrist Liberals and their former USR ally inched closer to rebuilding their majority ruling coalition on Wednesday, their leaders said, a first step toward ending a month-long political stalemate jeopardising reforms.

Seven-year-old Gael Coreas stuck out his left arm fearlessly to receive his first COVID-19 shot at a health clinic in the nation's capital on Wednesday, wincing briefly as cameras flashed to capture the moment.

The following are some of the factors that may move German stocks on Wednesday:

U.S. President Joe Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill, but agreed to move ahead with a far less ambitious proposal after facing opposition from centrist dissenters in Congress.

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown COVID-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.